IPO Boutique

Cidara Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Cidara Therapeutics , and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Cidara Therapeutics CDTX -
NASDAQ
$14.00-$16.00 $16.00 $16.114.8 million4/15/2015
Jefferies, Leerink Partners
Co-Manager(s):
Wedbush Pacgrow Life Sciences, Needham & Co., BTIG
Health Care
Filing(s):

Filed 2015-03-13
Terms Added 2015-04-06



Cidara Therapeutics Quote & Chart - Click for current quote - CDTX

About Cidara Therapeutics (adapted from Cidara Therapeutics prospectus):
They are a biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CDTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved